Clinical Trials Browser

Recruiting × Interventional × Meningioma × Clear all

NCT06955169 2026-04-16

MOMENTUM-1

Phase 2 Recruiting

Meningioma

NCT06607692 2026-04-14

LUPARPED

Phase 1/2 Recruiting

CNSEndocrineNETSarcoma

Adrenal Cortex Neoplasms, Adrenal Gland Neoplasms, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neuroblastoma, Paraganglioma, Pheochromocytoma, Recurrence, Osteosarcoma, Sarcoma, Synovial, Esthesioneuroblastoma, Olfactory, Neuroendocrine Tumors

NCT05278208 2026-04-13

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

Phase 1/2 Recruiting

Diffuse Intrinsic Pontine Glioma, Ependymoma, Glioma, Medulloblastoma, Meningioma, Neoplasms, Germ Cell and Embryonal, Central Nervous System Neoplasms

NCT02523014 2026-04-07

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

Phase 2 Recruiting

Meningioma

NCT06275919 2026-03-27

MIRAGE

Phase 2 Recruiting

Meningioma

NCT07413796 2026-03-27

NEURO-SUTURE

Phase NA Recruiting

Brain Neoplasms, Glioblastoma, Glioma, Meningioma

NCT05940493 2026-03-13

Abemaciclib in Newly Diagnosed Meningioma Patients

Phase 2 Recruiting

Meningioma

NCT06104930 2026-03-10

MOLI

Phase NA Recruiting

Meningioma

NCT05425004 2026-03-05

Cabozantinib for Patients With Recurrent or Progressive Meningioma

Phase 2 Recruiting

Meningioma, Central Nervous System Neoplasms

NCT06377371 2026-02-27

Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE

Phase 4 Recruiting

Meningioma

NCT06878469 2026-02-19

SIMPLIF-AI

Phase NA Recruiting

Brain Neoplasms, Meningioma

NCT04278118 2026-02-17

HiPPI

Phase NA Recruiting

Brain Neoplasms, Meningioma, Neurilemmoma, Pituitary Neoplasms, Nerve Sheath Neoplasms

NCT05957679 2026-02-12

MRE Evaluation for Spinal Cord Tumor Surgery: Stiffness and Adhesion Assessment

Phase NA Recruiting

Astrocytoma, Ependymoma, Glioblastoma, Glioma, Meningioma, Neurofibroma, Spinal Cord Neoplasms

NCT06955208 2026-02-12

3D MRE-Based Evaluation of Meningioma Mechanical Properties and Histological Features

Phase NA Recruiting

Tissue Adhesions, Meningioma

NCT06132685 2026-02-10

Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial

Phase 2 Recruiting

Brain Neoplasms, Meningioma

NCT05139277 2026-02-06

Evaluation of the CONVIVO System

Phase NA Recruiting

Brain Neoplasms, Glioblastoma, Glioma, Meningioma, Neurilemmoma, Pituitary Neoplasms

NCT06650163 2026-02-05

Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors

Phase 1 Recruiting

Brain Neoplasms, Glioma, Meningioma

NCT06752096 2026-01-16

Robot-Assisted Neurovascular Intervention

Phase NA Recruiting

Ischemic Stroke, Meningioma, Stroke

NCT03180268 2026-01-14

Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery

Phase 3 Recruiting

Meningioma

NCT04541082 2025-12-18

Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

Phase 1 Recruiting

Typical Teratoid Rhabdoid Tumor, Astrocytoma, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Oligodendroglioma, Pinealoma, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Neuroectodermal Tumors, Neuroectodermal Tumors, Primitive, Neoplasms, Neuroepithelial, Gliosarcoma

NCT04082520 2025-12-11

Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy

Phase 2 Recruiting

Meningioma

NCT04081701 2025-11-21

DOMINO-START

Phase 4 Recruiting

Medulloblastoma, Meningioma, Paraganglioma, Pituitary Neoplasms, Central Nervous System Neoplasms, Esthesioneuroblastoma, Olfactory, Hemangioblastoma

NCT06930846 2025-11-21

HOBSCOTCH-CA

Phase NA Recruiting

Caregiver Burden, Brain Neoplasms, Memory Disorders, Meningioma, Oligodendroglioma, Cognitive Dysfunction

NCT06326190 2025-09-16

LUMEN-1

Phase 2 Recruiting

Meningioma

NCT06831461 2025-09-16

PRIDE

Phase NA Recruiting

Brain Neoplasms, Meningioma, Pituitary Neoplasms

NCT06632860 2025-07-09

A Dual-targeting Tracer TATE-RGD for the Diagnosis of SSTR- and RGD- Positive Tumors

Phase EARLY_PHASE1 Recruiting

Meningioma

NCT02847559 2025-06-27

Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma

Phase 2 Recruiting

Meningioma

NCT06036706 2025-06-24

CANCER-COG

Phase NA Recruiting

Meningioma, Radiation Injuries

NCT05416567 2025-06-05

e-men

Phase NA Recruiting

Brain Neoplasms, Meningioma

NCT06014905 2025-05-25

Feasibility of Acquiring Hyperpolarized Imaging in Patients With Meningioma

Phase 1 Recruiting

Meningioma

NCT04997317 2025-04-13

PROMENADE

Phase 1/2 Recruiting

Meningioma, Neoplasms

NCT05793034 2025-03-13

23Men

Phase NA Recruiting

Meningioma

NCT06126588 2025-03-11

ELUMEN

Phase 2 Recruiting

Meningioma

NCT06830356 2025-02-17

SPIDER-MEN

Phase NA Recruiting

Meningioma

NCT06710249 2025-01-27

AFBTEdema

Phase 2 Recruiting

Brain Edema, Glioblastoma, Meningioma

NCT06557512 2025-01-08

SRS-AIM

Phase NA Recruiting

Meningioma

NCT06684795 2024-11-12

FG001 in Subjects with Meningiomas or Presumed Low-Grade Gliomas Scheduled for Neurosurgery

Phase 2 Recruiting

Glioma, Meningioma

NCT06640582 2024-11-05

BAH2472

Phase 1/2 Recruiting

Brain Neoplasms, Glioblastoma, Glioma, Meningioma

NCT04501705 2024-10-15

Apatinib in the Treatment of Recurrent Atypical/malignant Meningioma in Adults

Phase NA Recruiting

Meningioma

NCT03631953 2024-08-06

ALTREM

Phase 1 Recruiting

Meningioma

NCT05727605 2024-05-08

NARCiS

Phase NA Recruiting

Brain Neoplasms, Glioma, Meningioma, Pituitary Neoplasms